497 related articles for article (PubMed ID: 21073618)
1. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
Sun ZG; Wang Z
Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
[TBL] [Abstract][Full Text] [Related]
2. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Liu XY; Liu FY
World J Surg; 2011 Jan; 35(1):70-7. PubMed ID: 21046381
[TBL] [Abstract][Full Text] [Related]
3. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer.
Li SH; Wang Z; Liu XY; Liu FY; Sun ZY; Xue H
Surg Today; 2007; 37(12):1047-52. PubMed ID: 18030564
[TBL] [Abstract][Full Text] [Related]
4. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Sun ZG; Liu XY; Zhang M; Wang Z
Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-lewis esophagectomy in esophageal cancer.
Chen H; Wang Z; Yang Z; Shang B; Liu X; Chen G
Ann Surg Oncol; 2013 Aug; 20(8):2721-6. PubMed ID: 23463093
[TBL] [Abstract][Full Text] [Related]
6. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Song Y; Wang Z; Liu X; Jiang W; Shi M
Ann Surg Oncol; 2012 Oct; 19(11):3606-12. PubMed ID: 22644515
[TBL] [Abstract][Full Text] [Related]
7. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
8. Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients.
Akhtar J; Wang Z; Jiang WP; Bi MM; Zhang ZP
J Gastroenterol Hepatol; 2014 May; 29(5):944-50. PubMed ID: 24372619
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of detecting mucin 1 mRNA in diagnosing occult lymph node micrometastasis in esophageal cancer patients.
Liu XY; Chen G; Wang Z; Liu FY
Ai Zheng; 2007 Feb; 26(2):194-9. PubMed ID: 17298752
[TBL] [Abstract][Full Text] [Related]
11. Gene diagnosis and prognostic significance of lymph node micrometastasis after complete resection of histologically node-negative non-small cell lung cancer.
Li SH; Wang Z; Liu XY; Liu FY
World J Surg; 2008 Aug; 32(8):1651-6. PubMed ID: 18365271
[TBL] [Abstract][Full Text] [Related]
12. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection.
Lee DH; Kim HR; Kim DK; Park SI; Kim YH
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):365-71. PubMed ID: 23422046
[TBL] [Abstract][Full Text] [Related]
14. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
Chen G; Wang Z; Liu XY; Liu FY
World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
[TBL] [Abstract][Full Text] [Related]
15. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Zhang M
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e68-76. PubMed ID: 22897688
[TBL] [Abstract][Full Text] [Related]
16. [Impact of number and extent of lymph node metastasis on prognosis of thoracic esophageal cancer].
FENG J; MAO T; CHEN WH; FANG WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Sep; 14(9):715-8. PubMed ID: 21948541
[TBL] [Abstract][Full Text] [Related]
17. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
18. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
Shim YM; Park JS; Lee M; Kim D; Kim K
Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma.
Niwa Y; Koike M; Hattori M; Iwata N; Takami H; Hayashi M; Tanaka C; Kobayashi D; Kanda M; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23(2):611-8. PubMed ID: 26289807
[TBL] [Abstract][Full Text] [Related]
20. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
